Effect of MeCP2 on TGF- β 1-induced Extracellular Matrix Production in Nasal Polyp-derived Fibroblasts
Authors:
Open Access
- 20 April 2018
- journal article
- research article
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 32 (4) , 228-235
Abstract
Methyl-CpG-binding protein 2 (MeCP2), known as a transcriptional regulator, has been suggested to play an important role in myofibroblast differentiation in the lung. The purpose of this study was to investigate the role of MeCP2 in transforming growth factor (TGF)-β1-induced myofibroblast differentiation and extracellular matrix (ECM) production in nasal polyp-derived fibroblasts (NPDFs). To identify the expression of MeCP2 in nasal polyp tissues, immunohistochemistry staining and Western blot were performed. TGF-β1-induced NPDFs were treated with 5-azacytidine, a DNA methylation inhibitor, and the expression levels of α-SMA and fibronectin were determined by semiquantitative reverse transcription polymerase chain reaction, immunofluorescent staining, and Western blotting. The total soluble collagen was analyzed by the Sircol collagen assay. MeCP2 silenced by MeCP2-specific small interference (si) RNA was verified by Western blot. The expression levels of MeCP2 increased in nasal polyp tissues compared to normal inferior turbinate tissues. 5-Azacytidine significantly inhibited the expression of α-SMA and fibronectin mRNA in a dose-dependent manner. In addition, 5-azacytidine suppressed collagen production and the expression of MeCP2 in the same manner. The expression levels of a-SMA and collagen production were significantly blocked by MeCP2 silencing in TGF-β1-induced NPDFs. Our data suggest that MeCP2 plays an essential role in TGF-β1-induced myofibroblast differentiation and ECM production in NPDFs.Keywords
This publication has 22 references indexed in Scilit:
- The Role of the Fibroblast in Inflammatory Upper Airway ConditionsThe American Journal of Pathology, 2016
- Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposisJournal of Allergy and Clinical Immunology, 2015
- MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and FibrosisGastroenterology, 2010
- MeCP2, a Key Contributor to Neurological Disease, Activates and Represses TranscriptionScience, 2008
- EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 — a summaryPrimary Care Respiratory Journal, 2008
- The effect of transforming growth factor (TGF)-β1 and (TGF)-β2 on nasal polyp fibroblast activities involved upper airway remodeling: Modulation by fluticasone propionateImmunology Letters, 2006
- Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signalsNature Genetics, 2003
- Methyl CpG‐binding proteins and transcriptional repression*BioEssays, 2001
- Comparative Assessment of Cell Proliferation and Accumulation of Extracellular Matrix in Nasal PolypsActa Oto-Laryngologica, 1998
- Myofibroblast Accumulation Induced by Transforming Growth Factor‐β Is Involved in the Pathogenesis of Nasal PolypsThe Laryngoscope, 1997